The Eshelman Institute for Innovation is pleased to announce the recipients of their 2021 grant cycle! A total of $2.1 million has been granted to the below seven projects. Since 2015, the Eshelman Institute has brought value to the University … Continued
In 2012, a revolutionary new way to edit genes was unveiled to the world – CRISPR. Since then, the technology has been named as a “Breakthrough of the Year” by Science and has expanded to be applied to targeted epigenome … Continued
As part of the annual Eshelman Institute for Innovation (EII) student and postdoctoral grant process, the EII Rankin Innovator Acceleration Award is given annually to the student(s) with the highest rated, commercially focused proposal. The 2021 recipients of this award are … Continued
The Eshelman Institute for Innovation (EII) is pleased to announce the addition of four new Steering Board members. These individuals represent a broad array of experience in biopharmaceutical/therapeutic innovation, which will build on the talent of the existing Board Members. … Continued
As part of the annual Eshelman Institute for Innovation (EII) student and postdoctoral grant process, the EII Rankin Innovator Acceleration Award is given annually to the student(s) with the highest rated, commercially focused proposal. This year’s recipients include Ph.D. students Sabrina … Continued
The Eshelman Institute for Innovation (EII) is pleased to announce the recipients of its 2020 grant cycle. A total of $1.3M will be granted to the below six projects: Kevin Frankowski Center for Integrative Chemical Biology and Drug Discovery … Continued
The Structural Genomics Consortium (SGC), the University of North Carolina at Chapel Hill and the Eshelman Institute for Innovation, announce the launch of the Rapidly Emerging Antiviral Drug Discovery Initiative (READDI), to discover and develop drugs to put “on the … Continued
The Eshelman Institute for Innovation (EII) recently awarded Sam Lai, Ph.D., a $50,000 opportunistic grant to pursue COVID-19 research. The award will fund the development of a number of nebulized monoclonal antibody (mAb)-based therapy against COVID-19. This is based on … Continued
Lindsey Ingerman James ’10 (Ph.D.) was on the front lawn of Beard Hall with other Carolina professors when the largest gift from an individual in University history, and the largest ever made to a U.S. pharmacy school, was announced. “It … Continued
Dr. Soumya Rahima Benhabbour is from the North African country of Morocco where, according to UNAIDS, there has been a 42 percent reduction in new HIV infections since 2010. That’s good news to Benhabbour, whose dream is to empower women … Continued
